Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06047301 · ClinicalTrials.gov registry record · NA

Pathways, a Hope Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life During Advanced Lung Cancer Treatment

A NA study of Lung Cancer, sponsored by Laurie McLouth.

Recruiting
Registry status
NA
Development phase
234
Enrollment target
1
Study location

NCT06047301: Recruiting NA study of Lung Cancer, sponsored by Laurie McLouth.

NCT06047301 is a NA study of Lung Cancer that is actively recruiting participants, run by Laurie McLouth. The registered enrollment target is 234 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06047301, a NA study of Lung Cancer, is actively recruiting participants, sponsored by Laurie McLouth.

RECRUITING
Registry status
NA
Development phase
234 participants
Enrollment target
1
Study location

Study Summary

This study will compare the effects of a brief supportive intervention, called Pathways, against enhanced usual care on the mental health and quality of life of people undergoing treatment for advanced lung cancer. Patients will complete baseline survey measures and be randomized to intervention. Survey measures will be collected again mid-intervention, post-intervention and at 6- and 12-week follow-up, with analyses focused on changes pre- to post-intervention.

Conditions Studied

Interventions

  • BEHAVIORAL Enhanced Usual Care
  • BEHAVIORAL Pathways

Study Locations (1)

Kentucky

  • University of Kentucky - Lexington

Trial Details

FieldValue
Enrollment Target 234 participants
Start Date 2023-11-29
Est. Completion 2027-12-31
Phase NA

Sponsor

Laurie McLouth

3 total trials

What the Registry Record Tells You About NCT06047301

The ClinicalTrials.gov registry entry for NCT06047301 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 234 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (75% lower). The listed sponsor is Laurie McLouth, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Usual Care is the first listed.

NCT06047301 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT06047301 about?

NCT06047301 is a clinical study titled "Pathways, a Hope Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life During Advanced Lung Cancer Treatment". This study will compare the effects of a brief supportive intervention, called Pathways, against enhanced usual care on the mental health and quality of life of people undergoing treatment for advanced lung cancer. Patients will complete baseline survey measures and be randomized to intervention. Su...

What is the current status of trial NCT06047301?

This trial is currently recruiting. It is a NA study. The enrollment target is 234 participants. The study started on 2023-11-29. Estimated completion is 2027-12-31.

What conditions does trial NCT06047301 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT06047301?

The interventions under investigation include: Enhanced Usual Care (BEHAVIORAL), Pathways (BEHAVIORAL).

Who is sponsoring clinical trial NCT06047301?

This trial is sponsored by Laurie McLouth, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06047301 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.